KWANGDONG PHARMACEUTICAL CO.,LTD Logo

KWANGDONG PHARMACEUTICAL CO.,LTD

Developing drugs & health goods by integrating oriental and Western medicine.

009290 | KO

Overview

Corporate Details

ISIN(s):
KR7009290008
LEI:
Country:
South Korea
Address:
경기도 과천시 과천대로7다길 52 광동 과천 타워, 과천시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kwangdong Pharmaceutical Co., Ltd. is a human healthcare company established in 1963, built on the founding philosophy of integrating traditional oriental medicine with modern Western science. The company researches, develops, manufactures, and markets a diverse portfolio of products. This includes prescription (ETC) and over-the-counter (OTC) drugs, alongside a wide range of consumer health goods such as functional drinks, general supplements, and traditional health foods. Kwangdong is committed to improving national health through continuous R&D, aiming to create differentiated products and new value in both pharmaceuticals and health-aid foods.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 7.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 4.7 MB
2025-07-30 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 6.6 KB
2025-07-25 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 6.2 KB
2025-07-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.4 KB
2025-06-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.5 KB
2025-06-26 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 5.8 KB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 969.3 KB
2025-05-29 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 5.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.9 MB
2025-05-13 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.0 KB
2025-05-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.5 KB
2025-04-30 00:00
Legal Proceedings Report
[기재정정]재해발생
Korean 12.6 KB
2025-04-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 138.2 KB
2025-04-04 00:00
Regulatory News Service
[기재정정]생산중단
Korean 13.9 KB

Automate Your Workflow. Get a real-time feed of all KWANGDONG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KWANGDONG PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KWANGDONG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea
196170
ALTERITY THERAPEUTICS LTD Logo
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
Alto Neuroscience, Inc. Logo
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
ALUMIS INC. Logo
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America
AMRN
AMGEN INC Logo
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America
AMGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.